Phillips Academy
Michael Schmertzler is an accomplished professional with extensive experience in biotechnology, investment, and education. Currently serving as a Charter Trustee at Phillips Academy and Chairman of the Board at SHY Therapeutics and PTC Therapeutics, Schmertzler has a significant role in developing innovative cancer therapeutics. In addition, Michael is a Board Member at Berryville Holdings, LLC, and has contributed to academia as a Lecturer at Yale University. With past leadership positions including CEO of Kolltan Pharmaceuticals and managing director roles at Credit Suisse First Boston and Morgan Stanley, Schmertzler brings a wealth of knowledge in finance and corporate governance. Educational credentials include an MBA from Harvard Business School, as well as degrees from Princeton University and Yale University.
This person is not in the org chart
This person is not in any offices
Phillips Academy
Phillips Academy, better known as Andover, is a coeducational independent high school of approximately 1,100 students, known for its extensive and rigorous academic program. Founded in 1778, the Academy is comprised of a diverse community of teachers and students.